Evidence map›Paper›PMID 30756298›Full record

ArticleJournal of community genetics2020

Haemoglobinopathies in India: estimates of blood requirements and treatment costs for the decade 2017-2026.

Sujata Sinha, Tulika Seth, Roshan B Colah, Alan H Bittles

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of community genetics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Journal of obstetrics and gynaecology of India · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Global Globin Network and adopting genomic variant database requirements for thalassemia.Database : the journal of biological databases and curation · 2024
    Article
  11. Article
  12. Review
  13. Review
  14. Evaluation of Paper-Based Point of Care Screening Test for Sickle Cell Disease.Indian journal of clinical biochemistry : IJCB · 2022
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Sujata SinhaGenomics and Public Health Foundation, Dehradun, India. sujatasinha64@gmail.com.ORCID http://orcid.org/0000-0003-1230-5197
Tulika SethGenomics and Public Health Foundation, Dehradun, India.
Roshan B ColahNational Institute of Immunohaematology, ICMR, Mumbai, India.
Alan H BittlesCentre for Comparative Genomics, Murdoch University, Perth, Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Government of India is presently engaged in the implementation of a prevention and control programme for two major forms of haemoglobinopathies, thalassaemia major and sickle cell disease, with guidelines for their prevention and management formulated under the National Health Mission. Based on projections for the population up to the year 2026, the annual blood requirement for treatment will increase to 9.24 million units, together with an 86% increase in budgetary requirements which then would account for over 19% of the current National Health Budget. To avert a public health crisis there is an urgent need to fully implement the prevention programme for haemoglobinopathies.

Indexed as

Health budgetIndiaPublic healthSickle cell diseaseThalassaemiaTransfusion needs

Identifiers

PMID30756298
PMCPMC6962406

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.